
General Care and Management of Hemophilia
This eLearning module presents Section 1 of the WFH Guidelines for the Management of Hemophilia: General Care and Management of
Year: 2020
Language: English
Author(s): World Federation of Hemophilia
Format: Video
On December 10th, 2020 Glenn Pierce, WFH VP Medical moderated this one-hour webinar in the Public Health Webinar Series on Blood Disorders presented by the CDC.
The webinar discussed how the WFH Guidelines for the Management of Hemophilia, 3rd edition provides opportunities to improve the standard of diagnosis and care for people with hemophilia around the world.
Steven Pipe, Maggie Ragni, and Manuel Carcao, eminent hematologists and section leads in the development of the guidelines, presented details of the recently published recommendations on
Their presentations were followed by an extensive and informative Q&A session.
To view a pdf of the slides from the webinar, click on the icon below.
Source: U.S. Centers for Disease Control & Prevention, December 2020.
The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.
The WFH does not promote any particular pharmaceutical product and any mention of any commercial brand in this presentation is strictly for educational purposes.

This eLearning module presents Section 1 of the WFH Guidelines for the Management of Hemophilia: General Care and Management of

This eLearning module presents Section 5 of the WFH Guidelines for the Management of Hemophilia: Treatment of Specific Hemorrhages. Detailed

This eLearning module presents Section 3 of the WFH Guidelines for the Management of Hemophilia: Laboratory Diagnosis. Detailed illustrations, interactive

The World Federation of Hemophilia International Medical Card provides critical information to others in the case of an emergency.

A discussion of the mild forms of hemophilia A and hemophilia B, from epidemiology and molecular basis, via diagnosis, to

Acquired hemophilia is a rare condition caused by the production of autoantibodies, which inactivate factor VIII. This paper provides an